Hereditary motor and sensory neuropathy with treatable extrapyramidal features

S. Jaradeh, Peter J Dyck

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Seven patients with a sensorimotor peripheral neuropathy followed years later by extrapyramidal manifestations are presented. This appears to be a separate genetic disorder(s) from that described as Machado-Joseph disease. In five subjects, other relatives had similar multisystem involvement. None was of known Portuguese ancestry. The extrapyramidal syndrome was mainly parkinsonian. Pain was prominent in five subjects. In all cases, low or moderate doses of levodopa/carbidopa ameliorated both the pain and the parkinsonian features. In one patient, a randomized placebo-controlled trial of levodopa/carbidopa was found to significantly improve most symptoms and neurologic dysfunction scores related to the extrapyramidal syndrome.

Original languageEnglish (US)
Pages (from-to)175-178
Number of pages4
JournalArchives of Neurology
Volume49
Issue number2
StatePublished - 1992

Fingerprint

Hereditary Sensory and Motor Neuropathy
Machado-Joseph Disease
Pain
Inborn Genetic Diseases
Peripheral Nervous System Diseases
Neurologic Manifestations
Randomized Controlled Trials
Placebos
levodopa drug combination carbidopa
Syndrome

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Hereditary motor and sensory neuropathy with treatable extrapyramidal features. / Jaradeh, S.; Dyck, Peter J.

In: Archives of Neurology, Vol. 49, No. 2, 1992, p. 175-178.

Research output: Contribution to journalArticle

@article{11d8507b89334f2f9bfebebd1276a3c4,
title = "Hereditary motor and sensory neuropathy with treatable extrapyramidal features",
abstract = "Seven patients with a sensorimotor peripheral neuropathy followed years later by extrapyramidal manifestations are presented. This appears to be a separate genetic disorder(s) from that described as Machado-Joseph disease. In five subjects, other relatives had similar multisystem involvement. None was of known Portuguese ancestry. The extrapyramidal syndrome was mainly parkinsonian. Pain was prominent in five subjects. In all cases, low or moderate doses of levodopa/carbidopa ameliorated both the pain and the parkinsonian features. In one patient, a randomized placebo-controlled trial of levodopa/carbidopa was found to significantly improve most symptoms and neurologic dysfunction scores related to the extrapyramidal syndrome.",
author = "S. Jaradeh and Dyck, {Peter J}",
year = "1992",
language = "English (US)",
volume = "49",
pages = "175--178",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "2",

}

TY - JOUR

T1 - Hereditary motor and sensory neuropathy with treatable extrapyramidal features

AU - Jaradeh, S.

AU - Dyck, Peter J

PY - 1992

Y1 - 1992

N2 - Seven patients with a sensorimotor peripheral neuropathy followed years later by extrapyramidal manifestations are presented. This appears to be a separate genetic disorder(s) from that described as Machado-Joseph disease. In five subjects, other relatives had similar multisystem involvement. None was of known Portuguese ancestry. The extrapyramidal syndrome was mainly parkinsonian. Pain was prominent in five subjects. In all cases, low or moderate doses of levodopa/carbidopa ameliorated both the pain and the parkinsonian features. In one patient, a randomized placebo-controlled trial of levodopa/carbidopa was found to significantly improve most symptoms and neurologic dysfunction scores related to the extrapyramidal syndrome.

AB - Seven patients with a sensorimotor peripheral neuropathy followed years later by extrapyramidal manifestations are presented. This appears to be a separate genetic disorder(s) from that described as Machado-Joseph disease. In five subjects, other relatives had similar multisystem involvement. None was of known Portuguese ancestry. The extrapyramidal syndrome was mainly parkinsonian. Pain was prominent in five subjects. In all cases, low or moderate doses of levodopa/carbidopa ameliorated both the pain and the parkinsonian features. In one patient, a randomized placebo-controlled trial of levodopa/carbidopa was found to significantly improve most symptoms and neurologic dysfunction scores related to the extrapyramidal syndrome.

UR - http://www.scopus.com/inward/record.url?scp=0026511935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026511935&partnerID=8YFLogxK

M3 - Article

C2 - 1310584

AN - SCOPUS:0026511935

VL - 49

SP - 175

EP - 178

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 2

ER -